QBI’s scientific progress is powered by four pillars: technology, disease research, bridges between academia and industry, and people.
QBI’s technology ecosystem supports rapid, high-resolution exploration of biology. Tools ranging from cryo-EM/ET and mass spectrometry to CRISPR, microfluidics and structural modeling help researchers uncover insights that were once out of reach.
Through cell mapping, QBI reveals how proteins interact in health and disease, generating new insights across cancer, neuropsychiatric, and infectious diseases.
QBI bridges academia and industry through an integrated translational pipeline designed to better connect basic discovery with therapeutic development.
This evolving framework aims to align QBI’s academic research programs, affiliated companies, and foundation, helping to bridge longstanding gaps between academia and industry while supporting diversified, cross-sector funding.
QBI’s global network plays a central role in accelerating scientific discovery and strengthening cross-border research. By connecting scientists across institutions, disciplines, and regions, these partnerships bring new perspectives to shared challenges and help break down traditional silos in academia and industry.
